Compound Detail
CHEMBL1241359
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1241359 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZNEBVPDLAHSKDD-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
10
Publications
0
Known Names
Molecular Properties
313.2
MW (Da)
3.17
ALogP
4
HBA
2
HBD
62.2
PSA (Ų)
0.89
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 5.46
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Hepatitis B virus CHEMBL613497 | EC50 | 5.46 | 5.29 | 3500.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Hepatitis B virus | EC50 | = | 3500.0 | nM | 5.46 | Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cel... | 21553812 |
| Hepatitis B virus | EC50 | = | 7600.0 | nM | 5.12 | Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cel... | 21553812 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21553812 | 10.1021/jm200153p | Hepatitis B virus | 4 |
| 22059983 | 10.1021/jm201264t | Hepatitis C virus | 4 |
| 20047919 | 10.1128/aac.00614-09 | Cryptosporidium parvum | 2 |
| 20047919 | 10.1128/aac.00614-09 | HCT-8 | 2 |
| 21553812 | 10.1021/jm200153p | Unchecked | 2 |
| 22059983 | 10.1021/jm201264t | ADMET | 2 |
| 21553812 | 10.1021/jm200153p | ADMET | 1 |
| 22059983 | 10.1021/jm201264t | Rattus norvegicus | 1 |
| 22059983 | 10.1021/jm201264t | Canis familiaris | 1 |
| 22059983 | 10.1021/jm201264t | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine